Invenra and Catalent News and Resources

Invenra Inc., a bispecific antibody technology, has announced a strategic collaboration with Catalent to harness the combined expertise and proprietary technologies of both companies to co-discover novel bispecific antibody-drug conjugates. This partnership is expected to leverage Invenra’s bispecific antibody technology and